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Summary: The eyeless inbred mouse strain ZRDCT has
long served as a spontaneous model for human anoph-
thalmia and the evolutionary reduction of eyes that has
occurred in some naturally blind mammals. ZRDCT mice
have orbits but lack eyes and optic tracts and have
hypothalamic abnormalities. Segregation data suggest
that a small number of interacting genes are responsi-
ble, including at least one major recessive locus, ey1.
Although predicted since the 1940s, these loci were
never identified. We mapped ey1 to chromosome 18
using an F2 genome scan and there found a Met103Leu
mutation in Rx/rax, a homeobox gene that is expressed
in the anterior headfold, developing retina, pineal, and
hypothalamus and is translated via a leaky scanning
mechanism. The mutation affects a conserved AUG
codon that functions as an alternative translation initia-
tion site and consequently reduces the abundance of Rx
protein. In contrast to a targeted Rx null allele, which
causes anophthalmia, central nervous system defects,
and neonatal death, the hypomorphic M10L allele is fully
viable. genesis 31:43–53, 2001. © 2001 Wiley-Liss, Inc.
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INTRODUCTION
The phenotype of ZRDCT mice (Fig. 1a) is similar to
human clinical anophthalmia (Duke-Elder, 1964; Kohn et
al., 1988) and the rudimentary development of eyes in
some fossorial (subterranean) mammals (Cooper et al.,
1993). More than 90% of mice in this inbred strain have
no eyes or optic tracts, although the eyelids, bony orbits,
palpebral conjunctivae, Harderian glands, and periocular
soft tissues are intact (Chase and Chase, 1941; Silver and
Hughes, 1974). Higher visual centers in the brain, includ-
ing the lateral geniculate nuclei and visual cortex, form
normal projections and exhibit normal topographic con-
nectivity but are attenuated (Chase, 1945; Godement et
al., 1979; Katz et al., 1981; Olavarria and van Sluyters,
1984; Rhoades et al., 1985). The hypothalamus has vari-
ably distorted anatomy (Laemle and Rusa, 1992; Silver,
1977) and there are intrinsic circadian rhythm distur-
bances (Faradji-Prevautel et al., 1990; Laemle and Otten-
weller, 1998). The remaining 10% of ZRDCT mice have
one or two small eyes with colobomatous defects and no
optic nerve (Silver et al., 1984). The phenotype is first
apparent during lens induction at day E10. The optic
vesicles emerge normally from the anterior neural tube
but are reduced in size and contact poorly with the
surface ectoderm (Chase and Chase, 1941; Harch et al.,
1978; Silver and Hughes, 1974; Webster et al., 1984). In
some embryos, there is a small displaced lens placode
and limited crystallin synthesis (Konyukhov et al., 1978;
Zwaan and Silver, 1983). The eyeless trait is one of the
first developmental defects and first examples of multi-
factorial inheritance described in laboratory mice.
In crosses between ZRDCT and most other laboratory
strains, the eyeless phenotype behaves as a polygenic
trait. F1 mice are normal, but 10–13% of F2 intercross
and 20–25% of N2 backcross progeny are affected (Beck,
1963; Chase, 1942). On the basis of these experiments,
Chase (1944) postulated a major recessive eyeless deter-
minant (ey1) and a modifier (ey2) with partial domi-
nance. In this study, we test this model, identify the ey1
mutation, and characterize its molecular properties in
detail.
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RESULTS
To map ey1, we performed a pooled genome scan (Tay-
lor et al., 1994) using F2 progeny derived from ZRDCT
and CAST/Ei, an inbred strain of the relatively divergent
subspecies Mus musculus castaneus. Among 2,316 F2
offspring, we observed 2,109 normal (91.1%), 153 inter-
mediate (6.6%), and 54 bilaterally eyeless (2.3%) mice.
The proportion of affected F2 progeny is thus between
1/8 and 1/16. These ratios are similar to segregation data
reported for crosses between ZRDCT and conventional
laboratory mice (Beck, 1963; Chase, 1942; Chase, 1944).
By screening two pools of bilaterally anophthalmic F2
mice with multiple SSLP (simple sequence length poly-
morphism) markers, we detected linkage between ey1
and chromosome 18. We then singly tested all 54 eyeless
F2 mice using additional markers and a fragment length
polymorphism in the second intron of Rx/rax, a retinal
homeobox gene previously mapped to this region (Fu-
rukawa et al., 1997) (Fig. 1b). No recombination was
observed between Rx and ey1, suggesting that they are
located within 2.8 cM (95% CI for n 5 108 meioses, with
a LOD score in favor of linkage .30).
The Rx gene is an attractive candidate for ey1 for
several reasons. First, it encodes a 342 amino acid tran-
scription factor with four evolutionarily conserved mo-
tifs: a paired-class homeodomain, a C-terminal OAR
(paired tail) domain (Furukawa et al., 1997; Mathers et
al., 1997), an octapeptide motif near the N-terminus, and
a segment of high sequence conservation just beyond
the homeobox termed the Rx domain (Fig. 2a). Multiple
Rx homologues are known in the zebrafish, medaka,
chicken, and frog, and these can be divided into two
paralogous groups (Casarosa et al., 1997; Chuang et al.,
1999; Deschet et al., 1999; Ohuchi et al., 1999). Home-
odomain genes of this type are well known to regulate
morphogenesis. Second, Rx is one of the earliest retinal
patterning genes to be expressed, preceding Pax6 and
Chx10. It first appears at day E7.5 in regions of the
anterior neural plate and headfold that are fated to be-
come retina and is expressed most intensely in the optic
vesicle and cup between days E9 and E11 (Fig. 1c). Rx is
relatively specific to the developing eye but also appears
in the ventral forebrain, presumptive hypothalamus, and
posterior pituitary (Furukawa et al., 1997; Mathers et al.,
1997). This expression pattern has been generally well
conserved during vertebrate evolution. A Drosophila
homologue is expressed in the developing brain and
clypeolabrum but does not have a major role in eye
morphogenesis (Eggert et al., 1998). Third, Rx is re-
quired for optic vesicle formation. Mice homozygous for
an Rx null allele are anophthalmic but also die at birth
with major central nervous system and craniofacial de-
fects (Mathers et al., 1997).
To evaluate Rx as a candidate for ey1, we determined
its genomic structure and DNA sequence in ZRDCT,
CAST/Ei, and two conventional laboratory strains (Fig.
2b). The mouse Rx gene spans 5.6 kb and is divided into
three exons. We discovered a single nucleotide change
in the coding region that is unique to ZRDCT mice. The
change (ATG3TTG) causes an M10L amino acid substi-
tution and destroys an NcoI restriction site (Fig. 2b, c).
To confirm the relationship between Rx(M10L) and ey1,
we surveyed a variety of laboratory strains, wild-caught
mice, and other Mus species by PCR and NcoI digestion
(Fig. 2d). The M10L mutation was found in ZRDCT mice
from different sources but was absent from all other
mice tested, including C57BL strains which have a 4-10%
FIG. 1. Mapping ey1 in relation to
Rx/rax. (a) Phenotype of the
ZRDCT mice. (b) Segregation
data from 33 eyeless (ZRDCT 3
CAST/Ei) F2 progeny localize ey1
on chromosome 18 near Rx/rax.
Recombinant and nonrecombi-
nant chromosomes are repre-
sented vertically, along with the
total number observed in each
class. A genetic map of MMU18
derived from these data is shown
on the right. Distances (cM 6 SE)
are similar to those reported pre-
viously (Dietrich et al., 1994). An
additional 21 eyeless F2 mice were
typed at Rx/rax and D18Mit184. No
recombination was observed be-
tween these two markers and ey1.
f, ZRDCT; M, CAST/Ei genotypes.
(c) Whole-mount in situ hybridiza-
tion showing Rx/rax mRNA in the
optic vesicle of E9.5 and optic cup
of E10.5 embryos. Expression in
the optic cup is confined to the pre-
sumptive neural retina and does
not extend into the choroid fissure.
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background frequency of anophthalmia (Chase, 1942;
Pierro and Spiggle, 1967; Robinson et al., 1993; Smith et
al., 1994) and may share a common ancestry (Beck et al.,
2000; Chase, 1944) with the extinct B strain that is the
progenitor of ZRDCT. Moreover, a methionine codon is
present at position 10 in Rx genes of all other mammals
examined, including humans, rats, and six additional
phylogenetically diverse rodent species, and at the
equivalent position in Rx genes of fish, amphibians, and
birds (Fig. 3a, left, and data not shown). This methionine
codon thus exhibits a level of evolutionary sequence
conservation exceeding that found among vertebrate Rx
homeodomains, which are $96% identical. It is thus
improbable that the L10 allele is segregating within
mouse populations as a neutral polymorphism. We con-
clude that Rx(M10L) is most likely the ey1 determinant.
In principle, the M10L mutation could affect intrinsic
properties of the Rx protein or the efficiency of transla-
tion initiation. Although this methionine codon appears
to have been selectively retained among vertebrates for
at least 400 million years, the mutation itself is a conser-
vative amino acid substitution (an exchange between
hydrophobic residues) and does not occur within a pre-
viously defined functional domain. The identity of the Rx
start codon is also unclear, since the sequence surround-
ing the first in-frame methionine codon (M1) conforms
poorly to the consensus for translation initiation com-
pared with M10. In particular, the M1 site lacks a G at
position 14 and a purine at position 23, which are
considered critical for ribosome recognition via a cap-
dependent scanning mechanism (Kozak, 1996). These
three sequence characteristics are common to all verte-
brate Rx genes (Fig. 3a, right). The choice of initiation
site can also be significantly influenced by mRNA sec-
ondary structure (Kozak, 1990). To determine the true
initiation site and the effect of the M10L mutation in
vivo, we compared the size of Rx-myc fusion proteins
FIG. 2. The Rx(M10L) mutation. (a) Struc-
ture of the mouse Rx protein showing four
conserved motifs. (b) Genomic map of Rx
showing three exons, the 3-bp fragment
length polymorphism (FLP) used for link-
age mapping, the PCR primers used for
mutation screening (blue arrows), and the
M10L mutation. Homeobox segments
(yellow) are indicated within the coding
region (gray). The relevant ZRDCT nucle-
otide sequence is shown below the wild
type, along with the NcoI site (red text).
Complete genomic sequence data are
available from Genbank. (c) Southern
analysis of Rx confirming the loss of an
NcoI restriction site in ZRDCT mice. C,
C3H/HeJ; B, C57BL/6J; Z, ZRDCT. (d)
Survey of selected mouse strains for the
Rx(M10L) mutation. PCR products from
exon1 were digested with NcoI and elec-
trophoresed through a 3% agarose gel.
Similar results were obtained with DNA
samples from other strains and wild-
caught mice (see Methods).
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translated in cells transfected with mutant or wild-type
plasmid constructs (Fig. 3b). The fusion mRNAs contain
59 UTR sequences and the first 66 potential codons of
the mouse Rx gene. Proteins initiating at codons 1 or 10
are predicted to be 18.8 or 17.9 kDa, respectively. We
also tested control constructs containing an M1L substi-
tution or an optimal initiation sequence at M1. When the
wild-type fusion construct was tested, both methionine
codons were utilized as translation start sites (lane 6),
consistent with a leaky scanning model (Kozak, 1995).
The relative abundance of these two proteins presum-
ably reflects the balance between competing factors that
favor initiation at M1 (proximity to the 59 m7G cap)
versus M10 (context superiority for engaging the 40S
ribosomal subunit). The M10L mutation prevented initi-
ation at codon 10 and significantly lowered the effi-
ciency of Rx translation overall (compare lanes 5 and 6).
The decrease in translation efficiency was demonstrated
FIG. 3. The Rx(M10L) mutation affects translation initiation. (a) Left: N-terminal alignment of vertebrate Rx proteins. Sequences were
obtained from GenBank and are numbered in relation to mouse Rx/rax. Methionines (red) and residues that differ from mouse Rx/rax (blue)
are indicated. The methionine at position 9, 10, or 11 has been conserved during evolution. Right: Comparison of M1 and M9–11
translational start sites in vertebrate Rx mRNAs. The optimal sequence for translation initiation (Kozak, 1996) is shown below each
alignment, and the nucleotide matches are indicated in red text. In each case, the downstream site is a significantly more favorable context
than M1. (b) Western analysis of Rx-myc fusion polypeptides translated in vivo (transfected 293T cells). Left: Western blot showing
Myc-tagged proteins initiating at M1, M10, or M73 (within the pCS2MT vector). Lanes 1 and 2 contain mixtures of cell extracts from lanes
315 and lanes 415, respectively. The a-tubulin blot below is a loading control. Right: Magnified view of Myc Western blot (lanes 4–6). The
diagram below shows the framework pCS2MT expression construct and predicted protein products. Wild-type Rx mRNA starts translation
at both M1 and M10 codons. The M1. mRNA starts translation exclusively at M1, whereas the M1L mRNA starts translation exclusively
at M10. The M10L mutation eliminates the shorter product and decreases overall translation efficiency. MT, myc tag; ., optimal start site.
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most clearly by the appearance of an 11.1 kDa immuno-
reactive protein; this reflects ribosome scanning past
both codons 1 and 10 and initiation at the first in-frame
AUG codon of the pCS2MT vector (compare lanes 5 and
7). In contrast, the reciprocal M1L mutation prevented
initiation at codon 1 in vivo but did not significantly
lower overall translation (lane 4).
To assess the effect of the M10L mutation quantita-
tively in the context of the full-length Rx transcript, we
compared Rx protein levels in fetal retinal cells that
were transfected with either a mutant or wild-type ex-
pression plasmid (Fig. 4a). These plasmids express the
entire Rx mRNA, including the open reading frame and
UTRs, but differ by a single nucleotide. We observed a
significant reduction in the abundance of Rx protein
(compare lanes 3–6), which can best be explained by a
decrease in translation efficiency. The mutation does not
destabilize Rx mRNA, since wild-type and M10L tran-
scripts were equally abundant in this experiment (data
not shown) and in heterozygous (C3H/HeJ 3 ZRDCT) F1
embryos (Fig. 4b).
Finally, as a further functional test, we compared the
activity of Rx isoforms in a Xenopus RNA microinjection
assay (Andreazzoli et al., 1999; Mathers et al., 1997). We
first tested an M9L substitution in frog Xrx1 cDNA that is
equivalent to the ZRDCT mouse Rx mutation. When
injected into a D.1 blastomere of an 8-cell frog embryo,
M9L and wild-type Xrx1 RNAs were both capable of
inducing ectopic pigmented epithelium, although nei-
ther caused significant expansion of neural retina (data
not shown). We then compared the activity of mouse Rx
proteins initiating at M1 or M10 and M1-initiated pro-
teins with methionine or leucine at codon 10. We ob-
served a wide range of abnormal phenotypes on the
injected sides, including small or absent eyes, cyclopia,
retinal disruption, and ectopic pigmented epithelium
along the optic stalk (data not shown). These results
confirm that eye morphogenesis is sensitive to Rx dos-
FIG. 4. The M10L mutation reduces the abundance of Rx
protein, but not Rx mRNA. (a) Western analysis of HER10
retinal cells expressing full-length wild-type or M10L mutant
Rx mRNAs. Top: The level of Rx polypeptide (36 kDa, arrow)
is decreased approximately four-fold in duplicate cultures
transfected with pCS2(RxM10L) compared with wild-type
pCS2(Rx) plasmid. The M1- and M10-initiated Rx isoforms
are not resolved in this gel. Bottom: Endogenous a-tubulin
(57 kDa) shows equivalent protein loading. (b) M10L and
wild-type Rx transcripts are amplified equally from E14.5
(C3H/HeJ 3 ZRDCT) F1 embryos. An RT-PCR spanning
exons 1–3 was performed on total head RNA from four
littermates (lanes 1–4). The wild-type product is cleaved by
NcoI (554 bp) but the mutant product is resistant (824 bp).
These alleles are equally represented in the heterozygotes,
suggesting that the mRNAs are similarly expressed and sta-
ble. No product was amplified in the absence of reverse
transcriptase.
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age. (Fig. 5) (Table 1). However, there was no significant
qualitative difference between the mutant and wild-type
isoforms or between proteins initiating at M1 or M10 in
their effect on frog eye development. The ey1 mutation
thus does not grossly alter the intrinsic biological prop-
erties of Rx proteins.
DISCUSSION
Taken together, our findings show that ribosomes fre-
quently bypass the suboptimal M1 site and initiate at the
downstream M10 codon, producing two Rx proteins
that differ by nine amino acids from one mRNA. Al-
though rare, translational control by alternative start
codon usage from a single transcript can provide a fur-
ther opportunity to regulate protein function (Cornelis
et al., 2000; Hann et al., 1988; Liu et al., 1997; Markussen
et al., 1995; Sedman and Mertz, 1988). While this re-
mains a possibility for Rx, and the M10L mutation does
delete the shorter isoform, we believe the primary effect
of ey1 is a quantitative reduction in the synthesis of Rx
polypeptide. This effect was likely to be significantly
greater than two-fold a priori, since mice heterozygous
for a targeted Rx null allele are phenotypically normal
(Mathers et al., 1997). Indeed, our data suggest that the
M10L mutation decreases Rx translation by at least four-
fold (Figs. 3b, 4a). This result, together with (1) the
meiotic linkage between Rx and ey1; (2) the unique
M10L sequence alteration in the ZRDCT strain; (3) the
deep evolutionary conservation of M10; (4) the estab-
lished role of Rx and homeodomain proteins generally in
eye development; and (5) the specific effect of M10L on
alternative initiation, strongly suggests that Rx(M10L)
can be equated with ey1. A potentially similar but less
profound reduction in the efficiency of translation initi-
ation was reported for a mutation in codon 2 of the
human androgen receptor gene that causes a hypomor-
phic phenotype (Choong et al., 1996). In contrast, mis-
sense mutations affecting solitary start codons generally
cause a complete loss of function (Cheadle et al., 1994;
Tsujino et al., 1994; Waye et al., 1997). To our knowl-
edge, Rx(M10L) is the first example of a constitutional
mutation affecting an alternative start codon.
Our findings explain a number of previous observa-
tions regarding Rx and this strain. First, the eye and
hypothalamic phenotypes of ZRDCT mice closely match
the Rx expression pattern. Second, the M10L substitu-
tion is compatible with the behavior of ey1 as a hypo-
morphic allele. This is manifest during embryogenesis by
a graded reduction in the size of the optic vesicle and in
the adult phenotype. Third, explant data show an intrin-
sic growth defect in the neural retina of ZRDCT embryos
but not in lens primordia (Koniukhov and Iakovlev,
1986). Within the mouse eye, Rx expression is limited to
the optic cup and neural retina and is relatively indepen-
dent of Pax6 (Bernier et al., 2000; Zhang et al., 2000; NB
and TG, unpublished observations). Accordingly, mi-
crophthalmia or anophthalmia can result from mutations
in patterning genes that are expressed in the optic cup,
lens, or both (Breitman et al., 1987; Burmeister et al.,
1996; Ferda Percin et al., 2000; Hill et al., 1991; Hodgkin-
son et al., 1993).
Approximately one-half to two-thirds of the F2 mice
homozygous for the Rx(M10L) mutation have normally
sized eyes. This conclusion follows from the phenotypic
segregation data, which show fewer affected mice than
the 25% expected for a single recessive mendelian fac-
tor; the absence of excess perinatal lethality among the
F2 progeny and parental ZRDCT mice; and the finding of
M10L homozygotes in the normal F2 progeny class (data
not shown). The Rx(M10L) mutation is thus necessary
but not sufficient to produce anophthalmia in the
ZRDCT strain. This decreased penetrance and the phe-
notypic variability among affected F2 mice are reminis-
cent of anophthalmia and microphthalmia in some hu-
man pedigrees (Bateman, 1984). Our results suggest that
RX mutations may underlie some of these human disor-
ders (Voronina and Mathers, 2000). The inheritance pat-
tern also suggests that unlinked modifier gene(s), are
likely to interact with Rx in a developmental pathway for
the eye or otherwise control the threshold for pheno-
typic expression of ey1. Although a single modifier (ey2)
FIG. 5. Phenotypes resulting from overexpression of mouse Rx in Xenopus (shown at stages 39–41). RNA was injected into one dorsal
blastomere of each 8-cell embryo. (A) Abnormal pigmentation; (B) missing eye; (C) eyes joined at midline
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was originally proposed by Chase (1944), the actual
number of modifiers cannot be determined from segre-
gation data alone (Beck, 1963; Wright, 1968), since
their individual dominance characteristics and poten-
tial epistatic relationships are unknown. This number,
however, is likely to be small. The discovery of ey1
provides a basis to identify these genes. Comparable
modifier loci have been defined for mutations affect-
ing limb morphogenesis (Johnson et al., 1995; Sidow
et al., 1997) and other eye diseases (Bone-Larson et al.,
2000; Chang et al., 1999; Kajiwara et al., 1994).
Finally, as a synthetic trait involving a partial loss-of-
function mutation, the ZRDCT phenotype is suggestive
of the quantitative, polygenic interactions that underlie
the appearance and loss of morphological characteristics
during evolution (Grenier and Carroll, 2000; Wright,
1968). Extreme eye reduction is typical of troglobitic
(cave-dwelling) and fossorial species, which are found
within every class of vertebrates except birds. Adaptive
loss of function (Olson, 1999) involving quantitative
changes in the activity of genes such as Rx may thus
contribute to ocular regression in naturally blind species




The inbred ZRDCT strain (aa bb dd pp) was derived
(Beck, 1963) from the original B strain (bb dd) of Her-
man Chase, who received founders directly from C.C.
Little in 1938 (Chase, 1942). The eyeless phenotype was
first noted at the Jackson Laboratory within a colony of
strain R mice, among progeny of a wide cross, and was
positively selected by Little during the initial breeding
(Chase, 1949; Snell, 1941). To generate intersubspecific
F2 mice, we crossed eyeless ZRDCT males and females
to inbred Mus musculus castaneus mice (CAST/Ei, ob-
tained from the Jackson Laboratory) and intercrossed the
resulting F1 progeny. Phenotypes were scored two
weeks after birth when the eyelids had opened. Eyes
were classified according to Chase (1942) as normal,
small, or absent, and individual F2 pups as normal, eye-
less (bilateral anophthalmia), or intermediate (microph-
thalmia or unilateral anophthalmia). In cases where the
lids remained closed, the conjunctival sacs were ex-
plored and generally found to be anophthalmic. For RNA
analysis, we crossed ZRDCT males to C3H/HeJ females
and recovered F1 embryos on day E14.5 of gestation.
PCR Genotyping
A genome scan was performed using 58 SSLP mark-
ers distributed across the autosomes (Dietrich et al.,
1994). Genomic DNA from 12 severely affected F2
mice was divided into two equal pools (Taylor et al.,
1994). Markers were amplified for 40 cycles using
standard PCR conditions and primer pairs (Research
Genetics). Short, secondary PCRs (10 cycles) were
then performed with one 32P-end-labeled primer and
the products separated by electrophoresis through 6%
polyacrylamide sequencing gels. F2 pools were com-
pared with ZRDCT, CAST/Ei, and F1 genomic DNA
controls. Once linkage was detected, by an enrich-
ment of ZRDCT alleles in the pooled DNA, a larger set
of 54 eyeless F2 mice was typed individually using
additional markers on chromosome 18.
Rx Gene Analysis
Overlapping segments of mouse Rx were amplified
from ZRDCT, C3H/HeJ, C57BL/6J, and CAST/Ei genomic
DNA by high-fidelity long-range PCR (EXPAND, Roche)
using primers designed from the cDNA sequence (Fu-
rukawa et al., 1997; Mathers et al., 1997). Betaine (20%
v/v MasterAmp, Epicentre) was included in some reac-
tions to improve yield of GC-rich products. Terminal
fragments were recovered from BamHI-digested
genomic DNA by inverse PCR (Ochman et al., 1990).
The amplified products were sequenced directly and
used to assemble two Rx contigs. These are separated by
2.1 kb and correspond to exons 1–2 and 3 (accession
nos. AF319462 and AF319461). To localize Rx directly in
the F2 cross, we typed a 3-bp insertion in the second
intron, using PCR primers 59-CCTGTGGGTCAGAGAG-
GATAGCGAC-39 and 59-CTGGCGCCTCCACTTAGCCCG-
TCGG-39 which span 265 bp. Southern analysis of mouse
genomic DNA was performed using a 785-bp 59 Rx
cDNA probe (Mathers et al., 1997) and high stringency
wash conditions (0.1 3 SSC, 65°C). To demonstrate the
M10L Rx mutation, a 361-bp fragment of exon 1 was
amplified using primers 59-CTAAACTTGCAGCTCCAG-
CAGCGGG-39 and 59-GCCCAGGATGGCTTCGATGCT-
GTG-39 and digested with NcoI. The wild-type PCR prod-
uct is cleaved into 269- and 92-bp fragments, but the
M10L product is resistant to cleavage. We used this assay
to survey normal inbred laboratory mice (A/J, AU/SsJ,
Table 1




(wild type) Rx (M10L)
No. % No. %
Pigmentation abnormalities 114 62 87 39
Small or missing eyes 30 16 36 16
Eyes joined along midline 6 3 9 4
Other abnormal phenotypesa 3 2 11 5
Normal 32 17 81 36
Total 185 224
*RNA (10 pg) was transcribed in vitro from wild-type or M10L
pCS2(Rx) plasmids, injected into one dorsal blastomere of an 8-cell
embryo, and evaluated at stage 39–41. Although there was no
qualitative difference between mutant and wild type, the M10L RNA
was generally less potent, consistent with decreased translation
efficiency. Similar results were observed with wild-type and M9L
Xrx1 RNAs.
aOther phenotypes we observed include: no eyes, with random
pigmentation along the midline of the anterior head (most common);
one eye displaced anteriorly at midline; and no eyes, with no pig-
mentation.
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BALB/cJ, CBA/J, C3H/HeJ, C57BL/6J, C57BL/10J, C57BR/
cdJ, C57L/J, C58/J, DBA/2J, LT/ChRe, SJL/J, SWR/J, 129/
SvJ); Mus musculus castaneus (CAST/Ei), Mus spretus
(SPE/Ei), Mus musculus molossinus (MOLF/Ei), and a
Peruvian strain (PERA), each obtained as DNA from the
Jackson Laboratory; wild-caught Mus musculus and Mus
domesticus from the hybrid zone of Northern Europe
(kindly provided by Richard Sage); and eyeless ZRDCT
mice from colonies in Rhode Island (Harch et al., 1978)
and Moscow (Konyukhov et al., 1978), which have been
maintained separately for more than 20 years (kindly
provided by Neil Gonsalves and Boris Konyukhov).
RNA Analysis
Whole-mount in situ hybridization was performed on
wild-type CD1 mouse embryos as described (Brown et
al., 1998) using a 59 Rx cDNA probe (Mathers et al.,
1997). To test whether the M10L mutation affects tran-
script stability, we performed a reverse transcriptase
(RT) PCR assay on (C3H/HeJ 3 ZRDCT) F1 embryos.
Total RNA from E14.5 heads was randomly primed and
used to amplify 824-bp Rx cDNA products spanning
exons 1–3 with PCR primers 59-CTAAACTTGCAGCTC-
CAGCAGCGGG-39 and 59-CTGGCGCCTCCACTTAGC-
CCGTCGG-39. The reverse primer was 32P-end-labeled
and the PCR was for 30 cycles. Mutant and wild-type
transcripts differ by a single nucleotide. Their relative
abundance was determined by cleaving the radiolabeled
PCR products with NcoI and comparing the ratio of 824-
and 554-bp allelic fragments after polyacrylamide gel
electrophoresis. The two alleles amplified equally in con-
trol reactions performed on F1 genomic DNA.
Rx Plasmids
Mouse Rx cDNA clones with M10L and M1L mutations
(ATG3TTG) or optimal translation initiation sites
(Kozak, 1996) M1. and M10. (GCCACCATGG) were
created by oligonucleotide mutagenesis and restriction
endonuclease selection (Deng and Nickoloff, 1992). An
M9L mutation was introduced by the same method into
a frog Xrx1 cDNA clone in the pSP64RI vector (kindly
provided by Pete Mathers). Full-length mouse Rx expres-
sion constructs were created in pCS2 by ligating XbaI-
BsrGI fragments from 59 and 39 cDNA clones (Mathers et
al., 1997). To determine the exact site of translation
initiation, a panel of mutant and wild-type Rx-myc fusion
constructs was created in pCS2MT (Rupp et al., 1994;
Turner and Weintraub, 1994). The expression cassettes
contain 86 bp of 59UTR and the 66 amino-terminal
codons of mouse Rx, followed in frame by six tandem
Myc epitopes, and are transcribed in vivo from the sim-
ian CMV promoter. Fusion polypeptides starting at
codons M1 or M10 contain 166 or 157 amino acids,
respectively. The fusion constructs also contain an opti-
mal translation initiation sequence (AAAGCTATGG) at
M73 within the pCS2MT vector.
Cell Culture and Protein Analysis
Translation initiation was studied in vivo using 293T
human embryonic kidney cells. Cultures were trans-
fected with pCS2(Rx-myc) or control pCS2MT plasmids
by CaPO4 co-precipitation (2.5 mg per 60-mm dish).
After 48 h, whole-cell extracts were harvested in cold
lysis buffer (50 mM Tris, 150 mM NaCl, 1% NP40, pH
8.0) and clarified by centrifugation. To resolve fusion
proteins in the size range between 17 and 19 kDa,
supernatants were electrophoresed through a 14-cm
18% polyacrylamide gel for 10 h at 14 V/cm. The gel
buffer was 350 mM Bis-Tris, pH 6.5 and the running
buffer was 50 mM MOPS, 50 mM Tris, 0.1% SDS, 1 mM
EDTA, pH 7.7. Myc-tagged proteins were detected in
Western blots using 9E10 monoclonal antibody (1:200),
HRP-conjugated sheep anti-mouse IgG (1:20,000, Amer-
sham), and enhanced chemiluminescence (ECL) re-
agents (Renaissance, NEN). To confirm the interpreta-
tion of migration patterns, selected cell extracts from
mutant and control transfections were mixed and co-
electrophoresed. Similar results were obtained for
pCS2(Rx-myc) constructs in three different transfection
experiments. To verify that an equivalent amount of cell
extract was loaded in each lane and control for transfec-
tion efficiency, we probed nitrocellulose filters with a
monoclonal antibody (DM1A) that detects endogenous
a-tubulin (1:200, Neomarkers) or co-transfected a plas-
mid encoding an unrelated Myc-tagged protein.
To assess the efficiency of Rx translation overall, du-
plicate 60-mm cultures of Ad12 HER10 human embry-
onic retinal cells (Grabham et al., 1988) were co-trans-
fected in parallel with 1.0 mg of the full-length mutant or
wild-type Rx expression constructs or pCS2 vector. Plas-
mid DNAs were introduced using FuGENE6 reagent
(Roche). After 60 h, soluble proteins were extracted
from cells by lysis in cold RIPA buffer (150 mM NaCl,
1.0% NP40, 0.5% deoxycholate, 0.1% SDS, 50 mM Tris,
pH 8.0) and electrophoresed through 10% polyacryl-
amide SDS Bis-Tris gels (Novex, 20 mg per lane). After
transfer, Western blots were probed in series with poly-
clonal rabbit anti-RX IgG (1:200) and DM1A (a-tubulin).
The anti-RX IgG was purified from whole rabbit serum
(Kimura et al., 2000). Primary antibodies were detected
using HRP-protein A (1:5,000, KPL) or HRP-conjugated
sheep anti-mouse IgG (1:20,000, Amersham) and ECL
reagents (NEN). The relative abundance of Rx protein
was determined by densitometry from multiple ECL ex-
posures. The Rx mRNA levels in transfected cells were
equivalent by RT-PCR.
Xenopus RNA Microinjection
Capped RNA from wild-type and M9L mutant Xrx1
cDNA clones was synthesized in vitro using SP6 poly-
merase (Ambion) and microinjected using standard tech-
niques (Kanekar et al., 1997) into one of two D.1 blas-
tomeres in 8-cell Xenopus embryos. These dorsal
blastomeres normally form retinae, brain, and other an-
terior structures (Bauer et al., 1994). The injected Xrx1
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transcripts contain rabbit b-globin UTR sequences but
are not polyadenylated. We tested a range of Xrx1 RNA
amounts from 50 to 200 pg and co-injected a b-gal tracer
RNA (50 pg). Similar experiments were performed using
10 to 68 pg capped mouse Rx RNA derived from wild-
type, M1L, M10L, M1., M10. and M1./M10L clones in
pCS2 (Rupp et al., 1994; Turner and Weintraub, 1994);
these transcripts contain an SV40 polyA cassette that can
be utilized by injected Xenopus embryos, leading to
significantly higher levels of protein expression (D.L.
Turner, personal communication). Embryos were
stained for b-galactosidase at stage 39–41 and evaluated
under the dissection microscope and by histology. Tox-
icity was assessed by comparing the extent of staining in
embryos co-injected with Rx and b-gal RNAs to embryos
injected with b-gal RNA alone. Abnormal phenotypes
were assessed in comparison with the contralateral un-
injected sides as described (Mathers et al., 1997).
GenBank Accession Numbers
Mus musculus Rx/rax genomic DNA, AF319462 and
AF319461; Mus musculus Rx/rax cDNA, AF001906 and
U73177; Rattus norvegicus Rx genomic DNA, AF320224
and AF320225; Rattus norvegicus Rx cDNA AF135839;
Homo sapiens RX cDNA, AF115392; Xenopus laevis
Xrx1 cDNA, AF017273 and AF001048; Xenopus laevis
Xrx2 cDNA, AF001049; Gallus gallus cRx2/cRax2
cDNA, AF092538; Danio rerio Zrx1 cDNA, AF001907;
Danio rerio Zrx2 cDNA, AF001908; Danio rerio Zrx3
cDNA, AF001909; Astyanax mexicanus Rx1 cDNA,
AF264703; Oryzias latipes Rx2 cDNA, AJ007939.
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